Date: 2015-12-02
Type of information: Production agreement
Compound:
Company: Y-mAbs Therapeutics (USA - NY) Patheon Biologics (USA - NC)
Therapeutic area: Cancer - Oncology
Type agreement: production manufacturing
Action mechanism:
Disease:
Details: * On December 2, 2015, Y-mAbs Therapeutics announced that it has executed a manufacturing agreement with the international contract manufacturer organization Patheon Biologics (Patheon) for up-scaling of the production of its leading antibody compound, which is in clinical development for pediatric neuroblastoma and pediatric sarcoma. Under the agreement, Pantheon provides access to its worldwide network of biologic manufacturing facilities, with fill, finish and product release taking place at the Patheon Sterile North Facility in North Carolina USA.
Financial terms:
Latest news:
